Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues:
Total revenues	$ 32,825	$ 22,211	$ 63,711	$ 62,927
Expenses:
Cost of goods sold	5,021	3,812	11,922	12,538
Research and development	4,136	3,655	12,565	8,426
Selling, general and administrative	22,638	17,221	69,378	54,690
Asset impairment		106		106
Gain on foreign currency translation	(1,799)	(2,068)	(8,285)	(5,003)
Loss on purchase commitments				339
Total expenses	42,435	28,801	115,031	85,981
Loss from operations	(9,610)	(6,590)	(51,320)	(23,054)
Other (expense) income:
Interest income, net	663	36	1,556	64
Interest expense on financing liability	(2,466)		(7,280)
Interest expense on notes	(2,812)	(2,803)	(12,202)	(12,435)
Gain (loss) on extinguishment of debt, net		4,930		(17,200)
Other (expense) income	(207)	1	(207)	(240)
Total other expense	(4,822)	2,164	(18,133)	(29,811)
Loss before provision for income taxes	(14,432)	(4,426)	(69,453)	(52,865)
Net loss	$ (14,432)	$ (4,426)	$ (69,453)	$ (52,865)
Net loss per share - basic	$ (0.06)	$ (0.02)	$ (0.27)	$ (0.21)
Net loss per share - diluted	$ (0.06)	$ (0.02)	$ (0.27)	$ (0.21)
Shares used to compute net loss per share - basic	259,300	249,910	254,974	248,624
Shares used to compute net loss per share - diluted	259,300	249,910	254,974	248,624
Commercial product sales
Revenues:
Total revenues	$ 16,259	$ 9,753	$ 38,807	$ 27,828
Collaborations and services
Revenues:
Total revenues	10,346	12,458	18,380	35,099
Expenses:
Cost of revenue	12,439	$ 6,075	29,451	$ 14,885
Royalty collaborations
Revenues:
Total revenues	$ 6,220		$ 6,524